Medtech Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA examines dialysis equipment contamination:

This article was originally published in Clinica

Executive Summary

The FDA is examining reports of blood contamination in internal parts of dialysis equipment at several centres in the US. It is not yet clear how the contamination happened, but the agency warned that it is possible that blood borne pathogens could be transmitted from patient to patient. Since December 1998, several incidents of blood contamination during haemodialysis have occurred, according to a safety alert sent to dialysis centres and hospitals by the FDA's Center for Devices and Radiological Health.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT078370

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel